Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor-Reference-Cited by-同舟云学术

Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor

Published:2018-02-23 Issue:1 Volume:143 Page:151-159
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kim Hyun Jeong¹²³,Kang Sun Kyoung¹²,Kwon Woo Sun¹²,Kim Tae Soo¹²,Jeong Inhye¹²³,Jeung Hei-Cheul¹²⁴,Kragh Michael⁵,Horak Ivan D.⁵,Chung Hyun Cheol¹²³⁴,Rha Sun Young¹²³⁴^ORCID

Affiliation:

1. Songdang Institute for Cancer Research, Yonsei University College of Medicine; Seoul Republic of Korea

2. Yonsei Cancer Center, Yonsei University College of Medicine; Seoul Republic of Korea

3. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Seoul Republic of Korea

4. Division of Medical Oncology, Department of Internal Medicine; Yonsei Cancer Center, Yonsei University College of Medicine; Seoul Republic of Korea

5. Symphogen A/S; Ballerup Denmark

Funder

Ministry of Health and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014;Jung;Cancer Res Treat,2017

2. Role of chemotherapy in the treatment of gastroesophageal cancers;Hwang;Oncology,2007

3. Gastric cancer and trastuzumab: first biologic therapy in gastric cancer;Gunturu;Ther Adv Med Oncol,2013

4. Targeting the MET pathway in gastric and oesophageal cancers: refining the optimal approach;Lee;Clin Oncol (R Coll Radiol),2016

5. Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges;Bradley;Nat Rev Clin Oncol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer;Scientific Reports;2023-12-19

2. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer;Science Advances;2023-11-24

3. Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer;Journal of Clinical Oncology;2023-09-20

4. Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden;Clinical Chemistry;2022-10-28

5. Clinicopathological difference between gastric cancer in the lesser curvature and gastric cancer in the greater curvature;Medicine;2022-08-19